West Tower Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-176	Closed	-$6.26K	–	181
2023 Q4	$6.26K	Buy	176 +36	+26%	+$1.28K	0.01%	408
2023 Q3	$4.16K	Sell	140 -652	-82%	-$19.4K	﹤0.01%	501
2023 Q2	$14.3K	Buy	+792	New	+$14.3K	0.01%	374